IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C-Reference-Cited by-同舟云学术

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C

Published:2011-03-28 Issue:10 Volume:33 Page:1162-1172
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Fattovich G.,Covolo L.,Bibert S.,Askarieh G.,Lagging M.,Clément S.,Malerba G.,Pasino M.,Guido M.,Puoti M.,Gaeta G. B.,Santantonio T.,Raimondo G.,Bruno R.,Bochud P.-Y.,Donato F.,Negro F.,

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04635.x/fullpdf

Reference51 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Natural history of chronic hepatitis C;Seeff;Hepatology,2002

3. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

4. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who respond less well?;Zeuzem;Ann Intern Med,2004

5. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C;Bressler;Hepatology,2003

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of IL-28B serum level and gene polymorphism in a sample of Iraqi patients with ankylosing spondylitis;Asia Pacific Journal of Molecular Biology and Biotechnology;2023-02-27

2. Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg‐positive chronic hepatitis B naïve patients;Journal of Viral Hepatitis;2021-07-14

3. The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma;Journal of the Formosan Medical Association;2021-03

4. EASL Recognition Awardee 2020: Prof. Giovanna Fattovich;Journal of Hepatology;2020-09

5. Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges;International Journal of Medical Sciences;2020